Amiodarone Hydrochloride Patent Expiration

Amiodarone Hydrochloride was first introduced by Wyeth Pharmaceuticals Llc in its drug Cordarone on Dec 24, 1985. Other drugs containing Amiodarone Hydrochloride are Nexterone, Amiodarone Hydrochloride. 29 different companies have introduced drugs containing Amiodarone Hydrochloride.


Amiodarone Hydrochloride Patents

Given below is the list of patents protecting Amiodarone Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Nexterone US7635773 Sulfoalkyl ether cyclodextrin compositions Mar 13, 2029 Baxter Hlthcare
Nexterone US6869939 Formulations containing amiodarone and sulfoalkyl ether cyclodextrin May 04, 2022

(Expired)

Baxter Hlthcare



Amiodarone Hydrochloride's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Amiodarone Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Amiodarone Hydrochloride. The first generic version for Amiodarone Hydrochloride was by Upsher Smith Laboratories Llc and was approved on Apr 30, 1998. And the latest generic version is by Zhejiang Poly Pharm Co Ltd and was approved on Sep 11, 2024.

Given below is the list of companies who have filed for Amiodarone Hydrochloride generic, along with the locations of their manufacturing plants worldwide.